Statin Therapy for Hyperlipidemic Patients With Chronic Kidney Disease and End-Stage Renal Disease: A Retrospective Cohort Study Based on 925,418 Adults in Taiwan

Background: For non-dialysis patients with hyperlipidemia, statins may provide clinical benefits in reducing mortality risk; however, the optimal treatment for dialysis patients with hyperlipidemia remains debatable. We evaluated the mortality risks for hyperlipidemic patients with renal disorders a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sung, Fung-Chang, Jong, Ying-Chin, Muo, Chih-Hsin, Hsu, Chih-Cheng, Tsai, Wen-Chen, Hsu, Yueh-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930832/
https://www.ncbi.nlm.nih.gov/pubmed/35308209
http://dx.doi.org/10.3389/fphar.2022.815882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930832/
https://www.ncbi.nlm.nih.gov/pubmed/35308209
http://dx.doi.org/10.3389/fphar.2022.815882

Ejemplares similares